Search

Your search keyword '"Bosevski, M."' showing total 260 results

Search Constraints

Start Over You searched for: Author "Bosevski, M." Remove constraint Author: "Bosevski, M."
260 results on '"Bosevski, M."'

Search Results

1. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia

2. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism

3. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

4. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

5. COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding

6. Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry

7. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

8. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

9. Timing and characteristics of venous thromboembolism after noncancer surgery

10. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia

11. Comparative clinical prognosis of massive and non‐massive pulmonary embolism: A registry‐based cohort study

12. Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry

13. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

14. Blood Targets of Adjuvant Drugs Against COVID19

15. In vitro Fertilization Procedures with Embryo Transfer and Their Association with Thrombophilia, Thrombosis and Early Antithrombotic Treatments

18. Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry

19. Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism

20. Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism

21. Treatment of Right Heart Thrombi Associated with Acute Pulmonary Embolism

22. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

23. The Clinical Course of Venous Thromboembolism May Differ According to Cancer Site

24. Analysis of noncatheter-associated upper extremity deep venous thrombosis from the RIETE registry

25. DVT Management and Outcome Trends, 2001 to 2014

26. A RIETE registry analysis of recurrent thromboembolism and hemorrhage in patients with catheter-related thrombosis

27. A prognostic score to identify low‐risk outpatients with acute deep vein thrombosis in the upper extremity

28. Subsequent arterial ischemic events in patients receiving anticoagulant therapy for venous thromboembolism

29. Progression of carotid-artery disease in type 2 diabetic patients: a cohort prospective study

30. Bleeding risk in hospitalized patients with COVID‐19 receiving intermediate‐ or therapeutic doses of thromboprophylaxis

31. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

32. Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study

33. Edoxaban for the Long‐Term Therapy of Venous Thromboembolism: Should the Criteria for Dose Reduction be Revised?

34. Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism

35. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

37. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation

38. Real-Time Dissemination of Aggregate Data on Presentation and Outcomes of Patients With Venous Thromboembolism: The RIETE Infographics Project

39. D-dimer levels and risk of recurrence following provoked venous thromboembolism: findings from the RIETE registry

40. Timing and characteristics of venous thromboembolism after noncancer surgery

42. Predictors of active cancer thromboembolic outcomes

43. Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry

45. A Prognostic Score to Identify Low-risk Outpatients with Acute Deep Vein Thrombosis in the Lower Limbs

46. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

47. Venous Thromboembolism in Patients With Autoimmune Disorders: Findings From the RIETE Registry

48. Poster display I clinical general

49. First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry

50. Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry

Catalog

Books, media, physical & digital resources